Literature DB >> 3689376

The excretion of leukotriene E4 into urine following inhalation of leukotriene D4 by human individuals.

J Verhagen1, E H Bel, G M Kijne, P J Sterk, P L Bruynzeel, G A Veldink, J F Vliegenthart.   

Abstract

Healthy volunteers underwent bronchial challenge with increasing doses of nebulized leukotriene D4 (0.007 - 200 nmol) at 15 min intervals. Total amounts of 200 nmol (females) and 400 nmol (males) were inhaled, corresponding to approximately 100 nmol and 200 nmol deposited in the lung, respectively. Of the latter amounts 3 +/- 1% (mean +/- S.E.M., n = 5) was found to be excreted as leukotriene E4 into the urine within 12 h. No further excretion after this period was observed. Approximately 50% of the total urinary leukotriene E4 was excreted during the first 2 h. These results suggest that a possible formation of sulfidopeptide leukotrienes in the lung in vivo can be monitored by measuring leukotriene E4 excretion into the urine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689376     DOI: 10.1016/0006-291x(87)90955-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.

Authors:  I K Taylor
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine.

Authors:  S O'Sullivan; S E Dahlen; K Larsson; B M Larsson; P Malmberg; M Kumlin; L Palmberg
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

4.  Hepatic uptake and metabolic disposition of leukotriene B4 in rats.

Authors:  W Hagmann; M Korte
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

5.  Peptidoleukotriene (PLT) release and absorption from the airways of the isolated perfused guinea pig lung following chemical and antigenic challenge.

Authors:  R A Kovelesky; P R Byron; J Venitz
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

6.  Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.

Authors:  Tae-Rim Shin; Joo-Hee Kim; Cheol-Hong Kim; In-Gyu Hyun; Jeong-Hee Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99.

Authors:  Lora G Bankova; Juying Lai; Eri Yoshimoto; Joshua A Boyce; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

8.  Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.

Authors:  P Tagari; C Brideau; C Chan; R Frenette; C Black; A Ford-Hutchinson
Journal:  Agents Actions       Date:  1993-09

9.  Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.

Authors:  S A Green; M-P Malice; W Tanaka; C A Tozzi; T F Reiss
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

10.  Leukotrienes in the sputum and urine of cystic fibrosis children.

Authors:  A P Sampson; D A Spencer; C P Green; P J Piper; J F Price
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.